My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 217

    1.

    Long-term islet graft survival in NOD mice by abrogation of recurrent autoimmunity.

    Shi Q, Wang D, Hadley GA, Bingaman AW, Bartlett ST, Farber DL.

    Diabetes. 2004 Sep;53(9):2338-45.PMID: 15331543 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.

    Shi Q, Wang D, Hadley GA, Farber DL, Bartlett ST.

    Surgery. 2006 Aug;140(2):281-8.PMID: 16904981 [PubMed - indexed for MEDLINE]Related articles

    3.

    Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.

    Suarez-Pinzon W, Rajotte RV, Mosmann TR, Rabinovitch A.

    Diabetes. 1996 Oct;45(10):1350-7.PMID: 8826970 [PubMed - indexed for MEDLINE]Related articles

    4.

    Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.

    Drage M, Zaccone P, Phillips JM, Nicoletti F, Dawson J, Andrew Bradley J, Cooke A.

    Transplantation. 2002 Sep 15;74(5):611-9.PMID: 12352875 [PubMed - indexed for MEDLINE]Related articles

    5.

    Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy.

    Wu T, Levay-Young B, Heuss N, Sozen H, Kirchhof N, Sutherland DE, Hering B, Guo Z.

    Transplantation. 2002 Jul 15;74(1):22-7.PMID: 12134094 [PubMed - indexed for MEDLINE]Related articles

    6.

    Pig islet xenografts are resistant to autoimmune destruction by non-obese diabetic recipients after anti-CD4 treatment.

    Koulmanda M, Qipo A, Smith RN, Auchincloss H Jr.

    Xenotransplantation. 2003 Mar;10(2):178-84.PMID: 12588650 [PubMed - indexed for MEDLINE]Related articles

    7.

    Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.

    Nanji SA, Hancock WW, Luo B, Schur CD, Pawlick RL, Zhu LF, Anderson CC, Shapiro AM.

    Diabetes. 2006 Jan;55(1):27-33.PMID: 16380473 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Recurrent autoimmunity accelerates destruction of minor and major histoincompatible islet grafts in nonobese diabetic (NOD) mice.

    Okitsu T, Bartlett ST, Hadley GA, Drachenberg CB, Farney AC.

    Am J Transplant. 2001 Jul;1(2):138-45.PMID: 12099361 [PubMed - indexed for MEDLINE]Related articles

    9.

    A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic NOD mice.

    Guo Z, Wu T, Sozen H, Pan Y, Heuss N, Kalscheuer H, Sutherland DE, Blazar BR, Hering BJ.

    Transplantation. 2003 Apr 15;75(7):909-15.PMID: 12698073 [PubMed - indexed for MEDLINE]Related articles

    10.

    Combination of anti-CD4 with anti-LFA-1 and anti-CD154 monoclonal antibodies promotes long-term survival and function of neonatal porcine islet xenografts in spontaneously diabetic NOD mice.

    Arefanian H, Tredget EB, Rajotte RV, Korbutt GS, Gill RG, Rayat GR.

    Cell Transplant. 2007;16(8):787-98.PMID: 18087999 [PubMed - indexed for MEDLINE]Related articles

    11.

    Prevention of autoimmune islet allograft destruction by engraftment of donor T cells.

    Bartlett ST, Schweitzer EJ, Kuo PC, Johnson LB, Delatorre A, Hadley GA.

    Transplantation. 1997 Jan 27;63(2):299-303.PMID: 9020334 [PubMed - indexed for MEDLINE]Related articles

    12.

    BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice.

    Lakey JR, Singh B, Warnock GL, Rajotte RV.

    Transplantation. 1994 Apr 27;57(8):1213-7.PMID: 8178349 [PubMed - indexed for MEDLINE]Related articles

    13.

    Impact of donor immune cells in pancreatic islet transplantation.

    Carter JD, Chen M, Ellett JD, Smith KM, Nadler JL, Yang Z.

    Transplant Proc. 2004 Nov;36(9):2866-8.PMID: 15621170 [PubMed - indexed for MEDLINE]Related articles

    14.

    Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice.

    Li H, Kaufman CL, Ildstad ST.

    Surgery. 1995 Aug;118(2):192-7; discussion 197-8.PMID: 7638733 [PubMed - indexed for MEDLINE]Related articles

    15.

    Rapid destruction of encapsulated islet xenografts by NOD mice is CD4-dependent and facilitated by B-cells: innate immunity and autoimmunity do not play significant roles.

    Xu BY, Yang H, Serreze DV, MacIntosh R, Yu W, Wright JR Jr.

    Transplantation. 2005 Aug 15;80(3):402-9.PMID: 16082337 [PubMed - indexed for MEDLINE]Related articles

    16.

    Increasing donor chimerism and inducing tolerance to islet allografts by post-transplant donor lymphocyte infusion.

    Liu B, Hao J, Pan Y, Luo B, Westgard B, Heremans Y, Sutherland DE, Hering BJ, Guo Z.

    Am J Transplant. 2006 May;6(5 Pt 1):933-46.PMID: 16611329 [PubMed - indexed for MEDLINE]Related articles

    17.

    Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation.

    Kim SJ, Nian C, Doudet DJ, McIntosh CH.

    Diabetes. 2009 Mar;58(3):641-51. Epub 2008 Dec 10.PMID: 19073764 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Fas ligand-mediated mechanisms are involved in autoimmune destruction of islet beta cells in non-obese diabetic mice.

    Suarez-Pinzon WL, Power RF, Rabinovitch A.

    Diabetologia. 2000 Sep;43(9):1149-56.PMID: 11043861 [PubMed - indexed for MEDLINE]Related articles

    19.

    Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice.

    Luo X, Yang H, Kim IS, Saint-Hilaire F, Thomas DA, De BP, Ozkaynak E, Muthukumar T, Hancock WW, Crystal RG, Suthanthiran M.

    Transplantation. 2005 May 15;79(9):1091-6.PMID: 15880049 [PubMed - indexed for MEDLINE]Related articles

    20.

    Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.

    Makhlouf L, Grey ST, Dong V, Csizmadia E, Arvelo MB, Auchincloss H Jr, Ferran C, Sayegh MH.

    Transplantation. 2004 Apr 15;77(7):990-7.PMID: 15087759 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity